CME Group Inc. $CME Shares Acquired by Norinchukin Bank The

Key Points

• Norinchukin Bank increased its stake in CME Group Inc. by 15.4%, now holding 18,800 shares valued at approximately $4.99 million.
• Other institutional investors, such as GQG Partners and Wellington Management, significantly raised their positions in CME Group, indicating strong interest and confidence in the company.
• CME Group announced a dividend of $1.25 per share, representing a yield of 1.8%, with the payment scheduled for September 25th.

Norinchukin Bank The lifted its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 15.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,800 shares of the financial services provider's stock after purchasing an additional 2,507 shares during the period. Norinchukin Bank The's holdings in CME Group were worth $4,987,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of CME. GQG Partners LLC increased its stake in shares of CME Group by 7,676.3% in the 1st quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider's stock worth $584,975,000 after purchasing an additional 2,176,685 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of CME Group by 370.5% in the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider's stock worth $704,068,000 after purchasing an additional 2,089,935 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of CME Group by 32,941.0% in the 1st quarter. GAMMA Investing LLC now owns 1,858,887 shares of the financial services provider's stock worth $493,144,000 after purchasing an additional 1,853,261 shares in the last quarter. Nuveen LLC purchased a new stake in CME Group in the 1st quarter worth $218,842,000. Finally, Egerton Capital UK LLP increased its stake in CME Group by 79.4% in the 1st quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider's stock worth $459,003,000 after buying an additional 765,773 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Trading Up 0.0%

Shares of NASDAQ:CME traded up $0.02 during trading on Wednesday, reaching $271.63. 444,281 shares of the company were exchanged, compared to its average volume of 2,316,655. The firm has a market capitalization of $97.89 billion, a PE ratio of 26.29, a P/E/G ratio of 4.91 and a beta of 0.44. The business's fifty day simple moving average is $275.93 and its 200-day simple moving average is $268.87. CME Group Inc. has a 12-month low of $207.75 and a 12-month high of $290.79. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company's quarterly revenue was up 10.4% compared to the same quarter last year. During the same period last year, the company posted $2.56 earnings per share. On average, research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.8%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is presently 48.40%.

Insiders Place Their Bets

In other news, Director William R. Shepard purchased 256 shares of the business's stock in a transaction on Wednesday, June 25th. The shares were acquired at an average cost of $270.53 per share, with a total value of $69,255.68. Following the completion of the acquisition, the director owned 258,196 shares of the company's stock, valued at $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Charles P. Carey sold 500 shares of CME Group stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total transaction of $132,675.00. Following the completion of the transaction, the director directly owned 4,900 shares in the company, valued at $1,300,215. This represents a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Barclays set a $298.00 price objective on shares of CME Group and gave the company an "equal weight" rating in a report on Thursday, July 24th. Piper Sandler increased their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a report on Tuesday, July 15th. Wall Street Zen downgraded shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Citigroup increased their price target on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a report on Thursday, July 3rd. Finally, UBS Group reaffirmed a "neutral" rating and issued a $305.00 price target on shares of CME Group in a report on Thursday, July 24th. Four investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $261.93.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.